CLINICAL_TRIALS
ClinicalTrials.gov record update
Pilot Study: Detection of Carcinomas Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02293954
- Title field or adapter rule
- {'original_value': 'Pilot Study: Detection of Carcinomas Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)', 'source_field': 'protocolSection.identificationModule.officialTitle'}
- Ingested At
- 2026-10-31T23:27:25.007668+00:00
- Published At
- 2023-04-21T00:00:00+00:00
- Record Updated At
- 2026-09-24
- Results Posted At
- 2023-04-21
- Source Retrieved At
- 2026-10-31T22:17:54.613222+00:00
- Timestamp Basis
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
- Date limitation
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Breast Cancer", "Colon Cancer", "Extrahepatic Bile Duct Cancer", "Gallbladder Cancer", "Gastrointestinal Cancer", "Liver and Intrahepatic Biliary Tract Cancer", "Lung Cancer", "Metastatic Cancer", "Pancreatic Cancer", "Rectal Cancer", "Thyroid Gland Medullary Carcinoma", "Unspecified Adult Solid Tumor, Protocol Specific"]- protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-09-24", "type": "ACTUAL"}- protocolSection.identificationModule.nctId
"NCT02293954"- protocolSection.identificationModule.officialTitle
"Pilot Study: Detection of Carcinomas Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct
{"date": "2023-04-21", "type": "ACTUAL"}
Study condition terms
Interventions recorded in this study
- {'armGroupLabels': ['Diagnostic (copper Cu 64 anti-CEA monoclonal antibody M5A PET)'], 'description': 'Given copper Cu 64 anti-CEA monoclonal antibody M5A IV', 'name': 'radionuclide imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Diagnostic (copper Cu 64 anti-CEA monoclonal antibody M5A PET)'], 'description': 'Undergo PET', 'name': 'positron emission tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Diagnostic (copper Cu 64 anti-CEA monoclonal antibody M5A PET)'], 'description': 'Correlative studies', 'name': 'laboratory biomarker analysis', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Diagnostic (copper Cu 64 anti-CEA monoclonal antibody M5A PET)'], 'description': 'Correlative studies', 'name': 'pharmacological study', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Diagnostic (copper Cu 64 anti-CEA monoclonal antibody M5A PET)'], 'description': 'Cu 64 anti-CEA monoclonal antibody M5A IV', 'name': 'Cu 64 anti-CEA monoclonal antibody M5A IV', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
An intervention appearing in a study record does not establish an effect or an approved use.
Drug names recorded in this source
A recorded drug name is not by itself an indication or a condition-specific relationship.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.